IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q1 2023 Holdings

Filed 2023-04-27 | 6 holdings | $233.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$76.9M19,963,15732.9%
Vaxcyte Inc(PCVX)COM92243G108$54.6M1,457,30023.4%
Merus N VCOMN5749R100$29.4M1,600,00012.6%
Aura Biosciences Inc(AURA)COM05153U107$28.2M3,039,89212.1%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$26.5M2,000,00011.4%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$17.7M2,484,2747.6%